Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 9, 2012, Pages 547-552

  To, V T ^a   Huttl T P ^b,c   Lang, R ^b   Piotrowski, K ^a   Parhofer, K G ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Surgical Clinic   (Germany)

Author keywords

bariatric surgery; diabetes; dyslipidemia; metabolic syndrome; sleeve gastrectomy

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BARIATRIC SURGERY; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; LIFESTYLE MODIFICATION; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SLEEVE GASTRECTOMY; SURGICAL TECHNIQUE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GASTRECTOMY; GASTROPLASTY; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, UNIVERSITY; HUMANS; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; LAPAROSCOPY; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; PREVALENCE; RETROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84867423571     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1323738     Document Type: Article

References (54)

1. Finucane M. M., Stevens G. A., Cowan M. J. et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet: 2011; 377 557 567
2. Field A. E., Coakley E. H., Must A. et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med: 2001; 161 1581 1586 (Pubitemid 32681139)
3. Haslam D. W., James W. P. Obesity. Lancet: 2005; 366 1197 1209 (Pubitemid 41393598)
4. Xu W. L., Atti A. R., Gatz M. et al. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology: 2011; 76 1568 1574
5. Chan J. C., Cheung J. C., Stehouwer C. D. et al. The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome - an analysis by structural equation modelling. Int J Obes Relat Metab Disord: 2002; 26 994 1008 (Pubitemid 34756184)
6. Gastrointestinal surgery for severe obesity National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr: 1992; 55 615S 619S
7. Huttl T. P., Obeidat F. W., Parhofer K. G. et al. Operative techniques and outcomes in metabolic surgery: sleeve gastrectomy. Zentralbl Chir: 2009; 134 24 31
8. Karmali S., Johnson Stoklossa C., Sharma A. et al. Bariatric surgery: a primer. Can Fam Physician: 2010; 56 873 879
9. Schauer P. R., Burguera B., Ikramuddin S. et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003; 238 467 484 discussion 484-485
10. Ballantyne G. H., Farkas D., Laker S. et al. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg: 2006; 16 1189 1197 (Pubitemid 44433156)
11. Couzin J. Medicine. Bypassing medicine to treat diabetes. Science: 2008; 320 438 440
12. Monteiro Junior F. C., Silva Junior W. S., Salgado Filho N. et al. Effects of weight loss induced by bariatric surgery on the prevalence of metabolic syndrome. Arq Bras Cardiol: 2009; 92 418 422 35-39, 52-56
13. Batsis J. A., Romero-Corral A., Collazo-Clavell M. L. et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc: 2008; 83 897 907
14. Alberti K. G., Eckel R. H., Grundy S. M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120 1640 1645
15. McAuley K. A., Williams S. M., Mann J. I. et al. Diagnosing insulin resistance in the general population. Diabetes Care: 2001; 24 460 464 (Pubitemid 32198413)
16. Behrens C., Tang B. Q., Amson B. J. Early results of a Canadian laparoscopic sleeve gastrectomy experience. Can J Surg: 2011; 54 138 143
17. Snyder B., Wilson T., Mehta S. et al. Past, present, and future: Critical analysis of use of gastric bands in obese patients. Diabetes Metab Syndr Obes: 2010; 3 55 65
18. Kellum J. M., Kuemmerle J. F., ODorisio T. M. et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg: 1990; 211 763 770 discussion 770-771
19. Iannelli A., Anty R., Schneck A. S. et al. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Surgery: 2011; 149 364 370
20. Bellanger D. E., Greenway F. L. Laparoscopic sleeve gastrectomy, 529 cases without a leak: short-term results and technical considerations. Obes Surg: 2011; 21 146 150
21. Magee C. J., Barry J., Arumugasamy M. et al. Laparoscopic sleeve gastrectomy for high-risk patients: weight loss and comorbidity improvement - short-term results. Obes Surg: 2011; 21 547 550
22. Sanchez-Santos R., Masdevall C., Baltasar A. et al. Short- and mid-term outcomes of sleeve gastrectomy for morbid obesity: the experience of the Spanish National Registry. Obes Surg: 2009; 19 1203 1210
23. Pournaras D. J., Le Roux C. W. The effect of bariatric surgery on gut hormones that alter appetite. Diabetes Metab: 2009; 35 508 512
24. Karamanakos S. N., Vagenas K., Kalfarentzos F. et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg: 2008; 247 401 407
25. Korner J., Inabnet W., Febres G. et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond): 2009; 33 786 795
26. Langer F. B., Reza Hoda M. A., Bohdjalian A. et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg: 2005; 15 1024 1029 (Pubitemid 41116888)
27. Abbatini F., Rizzello M., Casella G. et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc: 2010; 24 1005 1010
28. Laville M., Disse E. Bariatric surgery for diabetes treatment: why should we go rapidly to surgery. Diabetes Metab: 2009; 35 562 563
29. Buchwald H., Avidor Y., Braunwald E. et al. Bariatric surgery: a systematic review and meta-analysis. JAMA: 2004; 292 1724 1737 (Pubitemid 39346675)
30. Dixon J. B., le Roux C. W., Rubino F. et al. Bariatric surgery for type 2 diabetes. Lancet: 2012; 379 2300 2311
31. Campos G. M., Rabl C., Peeva S. et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg: 2010; 14 15 23
32. Bose M., Teixeira J., Olivan B. et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes: 2010; 2 47 55
33. Morinigo R., Casamitjana R., Delgado S. et al. Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care: 2007; 30 1906 1908 (Pubitemid 47036380)
34. Miguel G. P., Azevedo J. L., Gicovate Neto C. et al. Glucose homeostasis and weight loss in morbidly obese patients undergoing banded sleeve gastrectomy: a prospective clinical study. Clinics (Sao Paulo): 2009; 64 1093 1098
35. Nosso G., Angrisani L., Saldalamacchia G. et al. Impact of sleeve gastrectomy on weight loss, glucose homeostasis, and comorbidities in severely obese type 2 diabetic subjects. J Obes: 2011; 2011 340867
36. Marantos G., Daskalakis M., Karkavitsas N. et al. Changes in Metabolic Profile and Adipoinsular Axis in Morbidly Obese Premenopausal Females Treated with Restrictive Bariatric Surgery. World J Surg: 2011
37. Rizzello M., Abbatini F., Casella G. et al. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg: 2010; 20 50 55
38. Kim W., Egan J. M. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev: 2008; 60 470 512
39. Peterli R., Wolnerhanssen B., Peters T. et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg: 2009; 250 234 241
40. Korner J., Bessler M., Inabnet W. et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis: 2007; 3 597 601 (Pubitemid 350091417)
41. Rodieux F., Giusti V., DAlessio D. A. et al. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring): 2008; 16 298 305 (Pubitemid 351271908)
42. Zhang F., Strain G. W., Lei W. et al. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy (LSG). Obes Surg: 2011; 21 305 309
43. Vidal J., Ibarzabal A., Romero F. et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg: 2008; 18 1077 1082
44. Wong A. T., Chan D. C., Armstrong J. et al. Effect of laparoscopic sleeve gastrectomy on elevated C-reactive protein and atherogenic dyslipidemia in morbidly obese patients. Clin Biochem: 2011; 44 342 344
45. Zambon S., Romanato G., Sartore G. et al. Bariatric surgery improves atherogenic LDL profile by triglyceride reduction. Obes Surg: 2009; 19 190 195
46. Corradini S. G., Eramo A., Lubrano C. et al. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg: 2005; 15 367 377 (Pubitemid 40463605)
47. Hady H. R., Dadan J., Luba M. The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material. Obes Surg: 2012; 22 13 22
48. Nguyen N. T., Varela E., Sabio A. et al. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg: 2006; 203 24 29
49. Andreelli F., Amouyal C., Magnan C. et al. What can bariatric surgery teach us about the pathophysiology of type 2 diabetes? Diabetes Metab: 2009; 35 499 507
50. Grundy S. M. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab: 2004; 89 2595 2600 (Pubitemid 38766337)
51. Ocon Breton J., Garcia B., Benito P. et al. Effect of gastric bypass on the metabolic syndrome and on cardiovascular risk. Nutr Hosp: 2010; 25 67 71
52. Sovik T. T., Irandoust B., Birkeland K. I. et al. Type 2 diabetes and metabolic syndrome before and after gastric bypass. Tidsskr Nor Laegeforen: 2010; 130 1347 1350
53. Gracia-Solanas J. A., Elia M., Aguilella V. et al. Metabolic syndrome after bariatric surgery. Results depending on the technique performed. Obes Surg: 2011; 21 179 185
54. Nugent C., Bai C., Elariny H. et al. Metabolic syndrome after laparoscopic bariatric surgery. Obes Surg: 2008; 18 1278 1286